World Swine Vaccine Market Driven by PCV2 Vaccination

The global swine industry increasingly relies on vaccination, according to Boehringer Ingelheim. With a total market value of €525 million in 2008, vaccines have become the most important health management tool for modern pig production (Vetnosis Ltd, March 2009).

The driver of this growth are vaccines against Porcine Circovirus Type 2 (PCV2), which have quickly become a standard vaccination in all major markets, alongside Mycoplasma vaccination programmes. The size of the PCV2-vaccine market is close to €180 million.

With total sales of ”€90 million, Boehringer's Ingelvac CircoFLEX was the global market leader in this segment last year (Animal Pharm, April 2009 and Boehringer Ingelheim).

Sign up for our
regular news updates

Related news items:

•    OIE Monitors Global Pandemic H1N1 2009 Situation
•    Guidance Document on Pig Protection Endorsed
•    New Merck Company Begins Operations
•    Influenza A/H1N1 Outbreak in Swine Confirmed
•    Pork with Anabolic Steroid Found in HCM City

Related News Categories: Pig Health, Company/Products

Sign up for our
regular news updates

More of the latest Pig Industry News

•   OIE Monitors Global Pandemic H1N1 2009 Situation
•   CPC Urges Action on Canada-Columbia FTA
•   Guidance Document on Pig Protection Endorsed
•   NFUS Urges Participation in Carbon Footprint Study
•   Defra's New Guidelines to Reduce Salmonella in Feed
•   Study to Bring Benefits to Meat Sector
•   New Merck Company Begins Operations
•   Influenza A/H1N1 Outbreak in Swine Confirmed
•   Ensuring the Most Exposed Animals the Best Welfare
•   Pork with Anabolic Steroid Found in HCM City